Hyerose Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 22-06-2024
- Paid Up Capital ₹ 0.10 M
as on 22-06-2024
- Company Age 6 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.90 M
as on 22-06-2024
- Revenue 129.40%
(FY 2020)
- Profit 96.49%
(FY 2020)
- Ebitda 1746.14%
(FY 2020)
- Net Worth -2.38%
(FY 2020)
- Total Assets 26.64%
(FY 2020)
About Hyerose Pharma
The Company is engaged in the Automotive Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.90 M.
Deepak Devinandana and Deepak Panikker serve as directors at the Company.
- CIN/LLPIN
U51909KL2018PTC054088
- Company No.
054088
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jul 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Alappuzha, Kerala, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Hyerose Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepak Devinandana  | Director | 05-Dec-2022 | Current |
| Deepak Panikker | Director | 18-Jul-2018 | Current |
Financial Performance of Hyerose Pharma.
Hyerose Pharma Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 129.4% increase. The company also saw a substantial improvement in profitability, with a 96.49% increase in profit. The company's net worth dipped by a decrease of 2.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hyerose Pharma?
In 2019, Hyerose Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 10 Jun 2020 | ₹0.15 M | Open |
Others Creation Date: 03 Nov 2018 | ₹0.75 M | Open |
How Many Employees Work at Hyerose Pharma?
Unlock and access historical data on people associated with Hyerose Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hyerose Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hyerose Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
